Mortality following new-onset Rheumatoid Arthritis: Has modern Rheumatology had an impact?

Annals of the Rheumatic Diseases

Volumn 77, Issue 1, 2018, Pages 85-91

  Holmqvist, Marie ^a   Ljung, Lotta ^b   Askling, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHOTREXATE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE EXACERBATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEALTH IMPACT ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; MORTALITY RISK; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SEX RATIO; SURVIVAL TIME; EPIDEMIOLOGY; MORTALITY; PROCEDURES; REGISTER; RISK FACTOR; SWEDEN; TIME FACTOR; TRENDS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RHEUMATOLOGY; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 85038258207     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2017-212131     Document Type: Article

References (19)

1. Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012;71:1524-9.
2. Myasoedova E, Davis JM, Crowson CS, et al. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep 2010;12:379-85.
3. Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017;76:960-77.
4. Gwinnutt JM, Symmons DPM, MacGregor AJ, et al. Twenty-Year outcome and association between early treatment and mortality and disability in an inception cohort of patients with rheumatoid arthritis: results rom the norfolk arthritis register. Arthritis Rheumatol 2017;69:1566-75.
5. Dadoun S, Zeboulon-Ktorza N, Combescure C, et al. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine 2013;80:29-33.
6. Radovits BJ, Fransen J, Al Shamma S, et al. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis. Arthritis Care Res 2010;62:362-70.
7. Lacaille D, Avina-Zubieta JA, Sayre EC, et al. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis 2017;76.
8. Humphreys JH, Warner A, Chipping J, et al. Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register. Arthritis Care Res 2014;66:1296-301.
9. CDC mortality statistics. Available at https://www.cdc.gov/nchs/data/databriefs/db88.htm#x2013;2010 (accessed 1 Jun 2017).
10. van den Hoek J, Boshuizen HC, Roorda LD, et al. Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatol Int 2017;37:487-93.
11. Zhang Y, Lu N, Peloquin C, et al. Improved survival in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis 2017;76:408-13.
12. Eriksson JK, Neovius M, Ernestam S, et al. Incidence of Rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res 2013;65:870-8.
13. Neovius M, Simard JF, Askling J. ART IS study group. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis 2011;70:624-9.
14. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659-67.
15. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Täckningsgrader 2015. Available at http://www.socialstyrelsen.se/publikationer2015/2015-12-8 (accessed 4 Jul 2016) In Swedish.
17. Widdifield J, Bernatsky S, Paterson JM, et al. Trends in excess mortality among patients with Rheumatoid Arthritis in Ontario, Canada. Arthritis Care Res 2015;67:1047-53.
18. Widdifield J, Paterson M, Huang A, et al. Risk of vascular mortality in seniors with New-Onset rheumatoid arthritis [abstract]. Arthritis Rheumatol. 2016;10. http://acrabstracts.org/abstract/risk-of-vascular-mortality-in-seniors-with-newonset-rheumatoid-arthritis/.
19. Kastbom A, Strandberg G, Lindroos A, et al. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 2004;63:1085-9.